{"type":"rich","version":"1.0","title":"The BioPharm Brief: Incentives, Immunity, and Iron","description":"Today’s BioPharm Brief covers rare disease investment, an FDA fast track designation for a Parkinson disease therapy, and phase 2 results for an siRNA treatment in polycythemia vera.","author_name":"The BioPharm Brief","author_url":"https://audioboom.com/channels/5167274-the-biopharm-brief","provider_name":"Audioboom","provider_url":"https://audioboom.com","width":480,"height":95,"thumbnail_url":"https://audioboom.com/i/43783908/600x600/c","thumbnail_width":600,"thumbnail_height":600,"html":""}